Print

Print


... despite these informations, I still prefer "structure factor  
amplitude", because it is the amplitude of the "structure factor" ...

Best regards,

Dirk.

Am 12.01.2009 um 11:42 schrieb Ian Tickle:

> I was taught 'structure amplitude' - makes perfect sense to me!  Why
> does 'structure amplitude' make any less sense than 'structure  
> factor'?
>
> It also clearly made sense to Phil Coppens, a crystallographer of
> considerable repute, see ITC Vol. B (2nd Ed.), sect 1.2., p.10: 'The
> Structure Factor'.  To quote the introduction to the section: "The
> 'structure factor' is the central concept in structure analysis by
> diffraction methods.  Its modulus is called the 'structure  
> amplitude'".
>
> Also I did a 'Google vote' for the two terms.  'Structure amplitude'  
> has
> 11300 hits.  'Structure factor amplitude' has only 4750.  So all  
> round I
> would say that 'structure amplitude' wins by a considerable margin.
>
> Cheers
>
> -- Ian
>
>> -----Original Message-----
>> From: [log in to unmask]
>> [mailto:[log in to unmask]] On Behalf Of Pavel Afonine
>> Sent: 11 January 2009 03:01
>> To: Ethan A Merritt
>> Cc: [log in to unmask]
>> Subject: Re: [ccp4bb] structure (factor) amplitude
>>
>>
>>
>> On 1/10/2009 5:14 PM, Ethan A Merritt wrote:
>>
>> 	On Saturday 10 January 2009, Bernhard Rupp wrote:
>> 	
>>
>> 		Dear All,
>> 		
>> 		I am getting conflicting comments on the use of
>> 		'structure factor amplitude'
>> 		vs. just
>> 		'structure amplitude'
>> 		for |F|.
>> 		
>>
>> 	
>> 	???
>> 	That's just... odd.
>> 	
>> 	|F| is the amplitude of F.
>> 	But no way F is a "structure".
>> 	
>>
>>
>> I agree. If F is a structure factor then |F| is a structure
>> factor amplitude. "structure amplitude" doesn't make much sense...
>> Pavel.
>
>
> Disclaimer
> This communication is confidential and may contain privileged  
> information intended solely for the named addressee(s). It may not  
> be used or disclosed except for the purpose for which it has been  
> sent. If you are not the intended recipient you must not review,  
> use, disclose, copy, distribute or take any action in reliance upon  
> it. If you have received this communication in error, please notify  
> Astex Therapeutics Ltd by emailing [log in to unmask]  
> and destroy all copies of the message and any attached documents.
> Astex Therapeutics Ltd monitors, controls and protects all its  
> messaging traffic in compliance with its corporate email policy. The  
> Company accepts no liability or responsibility for any onward  
> transmission or use of emails and attachments having left the Astex  
> Therapeutics domain.  Unless expressly stated, opinions in this  
> message are those of the individual sender and not of Astex  
> Therapeutics Ltd. The recipient should check this email and any  
> attachments for the presence of computer viruses. Astex Therapeutics  
> Ltd accepts no liability for damage caused by any virus transmitted  
> by this email. E-mail is susceptible to data corruption,  
> interception, unauthorized amendment, and tampering, Astex  
> Therapeutics Ltd only send and receive e-mails on the basis that the  
> Company is not liable for any such alteration or any consequences  
> thereof.
> Astex Therapeutics Ltd., Registered in England at 436 Cambridge  
> Science Park, Cambridge CB4 0QA under number 3751674


*******************************************************
Dirk Kostrewa
Gene Center, A 5.07
Ludwig-Maximilians-University
Feodor-Lynen-Str. 25
81377 Munich
Germany
Phone: 	+49-89-2180-76845
Fax: 	+49-89-2180-76999
E-mail:	[log in to unmask]
*******************************************************